Medicare News and Research

RSS

New UV light method could help stop spread of hospital superbugs

Can a robot clean a hospital room just as well as a person? According to new research out of the Texas A&M Health Science Center College of Medicine, that is indeed the case. Chetan Jinadatha, M.D., M.P.H., assistant professor at the Texas A&M College of Medicine and chief of infectious diseases at the Central Texas Veterans Health Care System in Temple, is studying the effectiveness of a germ-zapping robot to clean hospital rooms, which could hold the key to preventing the spread of "superbugs" - in turn, saving countless dollars and, most importantly, lives.

15 Apr 2015

Veracyte, GE parnter to develop new solutions to improve disease diagnosis

Veracyte, Inc., a molecular diagnostic company pioneering the field of molecular cytology, and GE today announced a research collaboration to develop new solutions that can improve disease diagnosis.

14 Apr 2015

Dependent coverage provision of ACA does not address racial disparities in trauma care

The Affordable Care Act allowed millions of young adults to retain health care coverage through their parents' insurance plans, but new research finds that many young African-American and Hispanic adults who need coverage for trauma care may not get it.

13 Apr 2015

Dependent care provision of ACA does not address racial gap in trauma care

The Affordable Care Act (ACA) allowed millions of young adults to retain health care coverage through their parents' insurance plans, but new research finds that many young African-American and Hispanic adults who need coverage for trauma care may not get it.

10 Apr 2015

National study comparing minimally invasive lumbar decompression (mild) with epidural steroid injections (ESIs) reaches full enrollment

Lumbar spinal stenosis is primarily a degenerative, age-related narrowing of the lower spinal canal resulting in compression of the nerve roots. MILD treats this compression by removing small portions of lamina and hypertrophic ligamentum flavum in a minimally invasive, outpatient procedure through an opening about the size of a baby aspirin...

9 Apr 2015

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Agendia, a leading molecular diagnostics company that develops and markets genomic diagnostic products, announced at the St. Gallen International Breast Cancer Conference that new guidelines of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) recommend the MammaPrint® 70-gene breast cancer recurrence assay in Germany’s 2015 guidelines for early-stage invasive breast cancer.

9 Apr 2015

Uninsured cancer patients may face higher charges for chemotherapy drugs

Uninsured cancer patients are asked to pay anywhere from two to 43 times what Medicare would pay for chemotherapy drugs, according to a new study from the University of North Carolina at Chapel Hill.

8 Apr 2015

Antipsychotic drugs may elevate child's risk for weight gain, type II diabetes

Today in JAMA Pediatrics, researchers from The Children's Hospital of Philadelphia's (CHOP) PolicyLab published the largest study to date documenting the significant risks to children's health associated with prescription antipsychotics, a powerful a class of medications used to treat mental and behavioral health disorders.

7 Apr 2015

Survey reveals growing needs, challenges faced by health plans serving vulnerable populations

Health Integrated, a leader in precision care management solutions, released the results today of an annual health plan survey jointly commissioned with the Association for Community Affiliated Plans, a national trade association representing nonprofit safety net health plans.

6 Apr 2015

Omeros announces commercial availability of Omidria in U.S.

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, announced today the nationwide commercial availability of Omidria (phenylephrine and ketorolac injection) 1%/0.3%.

2 Apr 2015

Study investigates health outcomes of Medicare beneficiaries enrolled in MA plans at member-level

Inovalon, a leading technology company providing advanced cloud-based analytics and data-driven intervention platforms to the healthcare industry and the Special Needs Plan (SNP) Alliance, released today the largest analysis ever performed on dual eligible quality outcomes, entitled "An Investigation of Medicare Advantage Dual Eligible Member-Level Performance on the Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Measures."

31 Mar 2015

COPD patients receiving home oxygen have higher risk of burn injury

Researchers from the University of Texas Medical Branch at Galveston have found that patients with chronic obstructive pulmonary disease receiving home oxygen have a higher risk of burn injury. This study was published on March 30 in Mayo Clinic Proceedings.

30 Mar 2015

Study finds C. difficile infection increases hospital readmission rates

Patients with Clostridium difficile infection (CDI) are twice as likely to be readmitted to the hospital as patients without the deadly diarrheal infection, according to a study published in the April issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology.

30 Mar 2015

Study identifies common causes of hospital readmissions following joint replacements procedures

A new study from researchers at NYU Langone's Hospital for Joint Diseases identifies common causes of hospital readmissions following total hip and knee arthoplasty procedures.

27 Mar 2015

Zyga reports commercial use of modernized SImmetry Sacroiliac Joint Fusion System for low back pain

Zyga Technology, Inc., a medical device company focused on the design, development and commercialization of minimally invasive devices to treat underserved conditions of the lumbar spine, today announced the launch and first commercial use of an updated SImmetry Sacroiliac Joint Fusion System. The surgery was performed by Dr. Brett Menmuir.

27 Mar 2015

AdverseEvents launches RxCost to determine economic impact of prescribing particular drugs

AdverseEvents Inc., a leading healthcare informatics company, today launched RxCost, the first methodology to identify the total costs of adverse drug reactions (ADRs) associated with FDA-approved drugs.

26 Mar 2015

Vermillion announces total revenue of $1.6 million for fourth quarter 2014

Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, reported on its results for the fourth quarter ended and full year ended December 31, 2014.

From Quest Diagnostics 25 Mar 2015

Qualcomm Life, AMC Health to accelerate transformation of health care delivery for at-risk patients

Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated, and AMC Health, a privately held provider of 'real-time' patient management solutions, today announced a collaborative effort to accelerate the transformation of chronic care and population health management by significantly enhancing connectivity and care coordination for at-risk patients, specifically those with heart failure, hypertension, diabetes, asthma or COPD, in a cost-effective manner.

25 Mar 2015

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

DaVita Clinical Research, a specialty contract research organization with services spanning the full spectrum of drug and device development and subsidiary of DaVita HealthCare Partners Inc., today announced that company representatives will present health-related quality posters at National Kidney Foundation's 2015 Spring Clinical Meeting, which takes place March 25-29, 2015 in Dallas.

25 Mar 2015

$HSS study examines racial and socioeconomic disparities in hip fracture care$

HSS study examines racial and socioeconomic disparities in hip fracture care

A study by researchers at Hospital for Special Surgery (HSS) finds that people in certain racial and socioeconomic groups are at a disadvantage when it comes to care they receive after fracturing a hip.

25 Mar 2015

Medicare News and Research

New UV light method could help stop spread of hospital superbugs

Veracyte, GE parnter to develop new solutions to improve disease diagnosis

Dependent coverage provision of ACA does not address racial disparities in trauma care

Dependent care provision of ACA does not address racial gap in trauma care

National study comparing minimally invasive lumbar decompression (mild) with epidural steroid injections (ESIs) reaches full enrollment

MammaPrint 70-gene breast cancer recurrence assay recommended in Germany’s AGO Guidelines

Uninsured cancer patients may face higher charges for chemotherapy drugs

Antipsychotic drugs may elevate child's risk for weight gain, type II diabetes

Survey reveals growing needs, challenges faced by health plans serving vulnerable populations

Omeros announces commercial availability of Omidria in U.S.

Study investigates health outcomes of Medicare beneficiaries enrolled in MA plans at member-level

COPD patients receiving home oxygen have higher risk of burn injury

Study finds C. difficile infection increases hospital readmission rates

Study identifies common causes of hospital readmissions following joint replacements procedures

Zyga reports commercial use of modernized SImmetry Sacroiliac Joint Fusion System for low back pain

AdverseEvents launches RxCost to determine economic impact of prescribing particular drugs

Vermillion announces total revenue of $1.6 million for fourth quarter 2014

Qualcomm Life, AMC Health to accelerate transformation of health care delivery for at-risk patients

DCR representatives to present health-related quality posters at NKF's 2015 Spring Clinical Meeting

HSS study examines racial and socioeconomic disparities in hip fracture care

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News